Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.
What Advanced files
- Others52
- Investor Meet40
- Updates19
- Board Meeting11
- Dividend/Bonus9
- PPTs9
Advanced Enzyme Technologies reported Q1 FY27 revenue of ₹189.8 Cr, up 2% YoY but down 7% QoQ. Profit (PAT) decreased 5% YoY to ₹38.6 Cr, while EBITDA fell 10% YoY to ₹51 Cr. Human Nutrition saw a 7% YoY dip, but Industrial Bio-processing surged 30% YoY to ₹30.6 Cr, driven...
Advanced Enzyme Technologies reported strong financial performance for Q4 FY26 and the full fiscal year. For Q4, revenue grew 22% year-on-year to ₹203.4 Cr, with profit after tax (PAT) soaring 69% to ₹45.3 Cr. Full FY26 revenue increased 17% to ₹745.8 Cr, and PAT climbed 30% to ₹173.6 Cr. Human...
Advanced Enzyme Technologies reported Q3 FY26 revenue up 2% YoY to ₹171.9 Cr, though EBITDA dipped 11% to ₹49.4 Cr. Despite this, Net Profit jumped 11% to ₹43.2 Cr, potentially aided by an exceptional gain. For the nine months, revenue grew 15% to ₹542.4 Cr, EBITDA rose 11% to ₹165.8...
Advanced Enzyme Technologies announced its consolidated financial results for the quarter and half-year. For Q2 FY26, revenue increased 26% YoY to ₹184.5 Cr, with a slight 1% QoQ dip. Profit After Tax (PAT) jumped 34% YoY to ₹44.7 Cr, and EBITDA grew 42% YoY to ₹60.1 Cr. EPS rose 32%...
Advanced Enzyme Technologies Limited (AETL) reported robust Q1 FY26 performance with revenue surging 20% year-on-year to ₹185.9 Crore. Profit After Tax (PAT) climbed 16% YoY to ₹40.4 Crore, and Earnings Per Share (EPS) rose 17% to ₹3.57. While full year FY25 revenue grew modestly by 2% to ₹636.9 Crore (PAT...